Gujarat Themis Biosyn Ltd details ₹1,351 crore acquisition of Japan’s MicroBioPharm
- MBJ reported FY26 revenue of ₹557 crore and EBITDA of ₹138 crore, a 25% margin.
- Presentation also lists refinancing of MBJ’s existing ₹632 crore loan.
- GTBL cited 990 KL fermentation capacity at its Vapi facility and plans to expand product, technology and geographic reach.
